Han CH et al. revealed that irradiation-induced AIM2 or NLRP3 inflammasome activation in macrophages can trigger IL-1 signaling pathway to conduct IL-1α release, which activates anti-tumor immunity and further improves the efficacy of radiotherapy 120. The gene discussed is IL1A; the disease is neoplasm.